Neutra Life Sciences
↗Houston, Texas
Neutra Life Sciences is a Site Management Organization (SMO) and a wholly owned subsidiary of Neutra Corp (OTC: NTRR). The company specializes in managing a network of clinical research sites to support Phase 1b through Phase 4 clinical trials across diverse therapeutic areas.
Originally focused on nutraceuticals and CBD, the company underwent a strategic pivot in 2024-2025 to focus primarily on clinical research services. It aims to bridge the gap between medical innovation and community-based healthcare by providing sponsors and CROs with high-quality, compliant research sites and diverse patient populations.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Clinical Research Site Management (SMO)
SIZE & FINANCIALS
Employees:1-50
Revenue:<$1M
Founded:2011
Ownership:subsidiary
Status:operating
FUNDING
Stage:Publicly Traded (Parent)
Total Raised:Unknown
Investors:Public Shareholders, Conventional Debt
STOCK
Exchange:OTC
Ticker:NTRR
Market Cap:$584K
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 4 (Service Provider)
Modalities:Small molecule, Medical Devices, Vaccines
Active Trials:5
Trial Phases:Phase 1: 1 | Phase 2: 2 | Phase 3: 2 | Phase 4: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Neutra Corp
Acquired By:Neutra Corp (Parent Company) (2022-01-01)
Key Partnerships:Parexel (Emerging Site Partnership), MediNet Family Care Clinic, Pediatric Center
COMPETITION
Position:Emerging
Competitors:Velocity Clinical Research, CenExel, Headlands Research
LEADERSHIP
Key Executives:
Sydney Jim - President and CEO
Bibiana Deaquiz - VP of Clinical Operations
LINKS
Website:neutralifesciences.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Neutra Life Sciences. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.